Serum S100B levels after meningioma surgery: A comparison of two laboratory assays

BMC Clinical Pathology

Volumn 8, Issue 1, 2008, Pages

  Einav, Sharon ^a   Itshayek, Eyal ^b   Kark, Jeremy D ^b   Ovadia, Haim ^b   Weiniger, Carolyn F ^b   Shoshan, Yigal ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S100B;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL PRACTICE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PROTEIN BLOOD LEVEL;

EID: 52949146384     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-8-9     Document Type: Article

References (45)

1. Serum S100β: A marker of brain damage in traumatic brain injury with and without multiple trauma. LE Pelinka E Toegel W Mauritz H Redl, Shock 2003 19 195 200 10.1097/00024382-200303000-00001 12630517
2. Serum S100β concentrations are increased after closed head injury in children: A preliminary study. RP Berger MC Pierce SR Wisniewski PD Adelson PM Kochanek, J Neurotrauma 2002 19 1405 1409 10.1089/089771502320914633 12490005
3. Protein S-100b serum levels in trauma-induced brain death. I Dimopoulou S Korfias U Dafni A Anthi C Psachoulia G Jullien DE Sakas C Roussos, Neurology 2003 60 947 951 10.1001/archneur.60.7.947 12654958
4. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. C Foerch OC Singer T Neumann-Haefelin R du Mesnil de Rochemont H Steinmetz M Sitzer, Arch Neurol 2005 62 1130 1134 10.1001/archneur.62.7.1130 16009772
5. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. BW Bottiger S Mobes R Glatzer H Bauer A Gries P Bärtsch J Motsch E Martin, Circulation 2001 103 2694 2698 11390339
6. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. H Rosen L Rosenberg J Herlitz C Blomstrand, Stroke 1998 29 473 477 9472892
7. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. N Weiss P Sanchez-Pẽa S Roche JL Beaudeux C Colonne P Coriat L Puybasset, Anesthesiolog 2006 104 658 666 10.1097/00000542- 200604000-00008
8. S100B protein in clinical diagnostics: assay specificity. CW Heizmann, Clin Chem 2004 50 249 251 10.1373/clinchem.2003.027367 14709667
9. Pediatric concentrations of S100B protein in blood: age- and sex-related changes. D Gazzolo F Michetti M Bruschettini N Marchese M Lituania S Mangraviti E Pedrazzi P Bruschettini, Clin Chem 2003 49 967 970 10.1373/49.6.967 12765999
10. Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. O Nygaard B Langbakk B Romner, Clin Chem 1997 43 541 543 9068602
11. Postoperative serum S100B levels predict postoperative brain damage in patients undergoing meningioma surgery. S Einav Y Shoshan H Ovadia I Matot M Hersch E Itshayek, Crit Care 2006 10 R141 17020600 10.1186/cc5058
12. Serum S-100B as an indicator of early postoperative deterioration after meningioma surgery. G Stranjalis S Korfias C Psachoulia E Boviatsis A Kouyialis D Protopappa DE Sakas, Clin Chem 2005 51 202 207 10.1373/clinchem.2004.039719 15550475
13. Statistical methods for assessing agreement between two methods of clinical measurement. JM Bland DG Altman, Lancet 1986 1 307 310 2868172
14. Rapid measurement of S-100B serum protein levels by Elecsys S100 immunoassay in patients undergoing carotid artery stenting or endarterectomy. T Mussack V Klauss V Ruppert C Gippner-Steppert P Biberthaler U Schiemann U Hoffmann M Jochum, Clin Biochem 2006 39 349 356 10.1016/j.clinbiochem.2005.12. 007 16460721
15. Plasma S-100b protein concentration in healthy adults is age- and sex-independent. M Wiesmann U Missler D Gottmann S Gehring, Clin Chem 1998 44 1056 1057 9590385
16. The serum S100B concentration is age dependent. LV Portela AB Tort DV Schaf L Ribeiro DB Nora R Walz LN Rotta CT Silva JV Busnello F Kapczinski CA Gonçalves DO Souza, Clin Chem 2002 48 950 952 12029017
17. S100 beta stimulates calcium fluxes in glial and neuronal cells. SW Barger LJ Van Eldik, J Biol Chem 1992 267 9689 9694 1315768
18. The S100 family of EF-hand calcium binding proteins: functions and pathology. BW Schäfer CW Heizmann, Trends Biochem Sci 1996 21 134 140 8701470
19. The S100 protein family: history, function, and expression. DB Zimmer EH Cornwall A Landar W Song, Brain Res Bull 1995 37 417 429 10.1016/0361-9230(95) 00040-2 7620916
20. S100B, a neurotropic protein that modulates neuronal protein phosphorylation, is upregulated during lesion induced collateral sprouting and reactive synaptogenesis. BS McAdory LJ Van Eldik JJ Norden, Brain Res 1998 813 211 217 10.1016/S0006-8993(98)01014-2 9824701
21. Neurotrophic protein S100 beta stimulates glial cell proliferation. RH Selinfreund SW Barger WJ Pledger LJ Van Eldik, Proc Natl Acad Sci USA 1991 88 3554 3558 1902567 10.1073/pnas.88.9.3554
22. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. R Donato, Biochim Biophys Acta 1999 1450 191 231 10.1016/S0167-4889(99)00058-0 10395934
23. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. A Bhattacharyya RW Oppenheim D Prevette BW Moore R Brackenbury N Ratner, J Neurobiol 1992 23 451 466 10.1002/neu.480230410 1634890
24. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. F Winningham-Major JL Staecker SW Barger S Coats LJ Van Eldik, J Cell Biol 1989 109 3063 3071 2592414 10.1083/jcb.109.6.3063
25. Purification and characterization of a neurite extension factor from bovine brain. D Kligman DR Marshak, Proc Natl Acad Sci USA 1985 82 7136 7139 3863143 10.1073/pnas.82.20.7136
26. Serum S-100B protein levels during and after successful carotid artery stenting or carotid endarterectomy. T Mussack C Hauser V Klauss F Tató J Rieger V Ruppert M Jochum U Hoffmann, J Endovasc Ther 2006 13 39 46 10.1583/05-1656.1 16445322
27. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. H Rosen L Rosenberg J Herlitz C Blomstrand, Stroke 1998 29 473 477 9472892
28. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. AA Kanner N Marchi V Fazio MR Mayberg MT Koltz V Siomin GH Stevens T Masaryk B Aumayr MA Vogelbaum GH Barnett D Janigro, Cancer 2003 97 2806 2813 10.1002/cncr.11409 12767094
29. Peripheral markers of blood-brain barrier damage. N Marchi M Cavaglia V Fazio S Bhudia K Hallene D Janigro, Clin Chim Acta 2004 342 1 12 10.1016/j.cccn.2003.12.008 15026262
30. Renal elimination of protein S-100beta in pigs with acute encephalopathy. LM Ytrebo GI Nedredal C Korvald OJ Holm Nielsen T Ingebrigtsen B Romner J Aarbakke A Revhaug, Scand J Clin Lab Invest 2001 61 217 225 10.1080/ 003655101300133658 11386608
31. Peripheral detection of S100beta during cardiothoracic surgery: what are we really measuring? V Fazio SK Bhudia N Marchi B Aumayr D Janigro, Ann Thorac Surg 2004 78 46 53 10.1016/j.athoracsur.2003.11.042 15223400
32. Cerebral and extracerebral release of protein S100B in cardiac surgical patients. SA Snyder-Ramos T Gruhlke H Bauer M Bauer AP Luntz J Motsch E Martin CF Vahl U Missler M Wiesmann BW Böttiger, Anaesthesia 2004 59 344 349 10.1111/j.1365-2044.2004.03663.x 15023104
33. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. RE Anderson LO Hansson O Nilsson J Liska G Settergren J Vaage, Ann Thor Surg 2001 71 1512 1517 10.1016/S0003-4975(01)02399-2
34. Tissue distribution of rat S100 alpha and S100 beta and S100-binding proteins. DB Zimmer LJ Van Eldik, Am J Physiol 1987 252 C285 289 3826357
35. Hormonal regulation of adipose S-100 protein release. F Suzuki K Kato T Nakajima, J Neurochem 1984 43 1336 1341 10.1111/j.1471-4159.1984.tb05391.x 6092538
36. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. C Arcuri I Giambanco R Bianchi R Donato, Neuroscience 2002 109 371 388 10.1016/S0306-4522(01)00330-X 11801372
37. Circulating S100B protein is increased in intrauterine growth retarded fetuses. D Gazzolo E Marinoni R Di Iorio M Lituania PL Bruschettini F Michetti, Pediatr Res 2002 51 215 219 10.1203/00006450-200202000-00015 11809917
38. Expression in the placenta of neuronal markers for perinatal brain damage. LD Wijnberger PG Nikkels AJ van Dongen CW Noorlander EJ Mulder LH Schrama GH Visser, Pediatr Res 2002 51 492 496 10.1203/00006450-200204000-00015 11919335
39. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. P Martens A Raabe P Johnsson, Stroke 1998 29 2363 2366 9804649
40. S-100 protein as early predictor of regaining consciousness after out of hospital cardiac arrest. S Hachimi-Idrissi M Van der Auwera J Schiettecatte G Ebinger Y Michotte L Huyghens, Resuscitation 2002 53 251 257 10.1016/S0300-9572(02)00027-8 12062839
41. Cardiopulmonary resuscitation: What cost to cheat death? KH Lee DC Angus NS Abramson, Crit Care Med 1996 24 2046 2052 10.1097/00003246-199612000-00019 8968275
42. Hospitalizations for critically ill children with traumatic brain injuries: a longitudinal analysis. JM Tilford ME Aitken KJ Anand JW Green AC Goodman JG Parker JB Killingsworth DH Fiser PD Adelson, Crit Care Med 2005 33 2074 2081 10.1097/01.CCM.0000171839.65687.F5 16148483
43. Long-term medical care utilization and costs among traumatic brain injury survivors. SJ Vangel Jr LJ Rapport RA Hanks KL Black, Am J Phys Med Rehabil 2005 84 153 160 10.1097/01.PHM.0000154896.55045.E7 15725788
44. Resource utilization and costs of stroke unit care integrated in a care continuum: A 1-year controlled, prospective, randomized study in elderly patients: the Goteborg 70+ Stroke Study. L Claesson G Gosman-Hedstrom M Johannesson B Fagerberg C Blomstrand, Stroke 2000 31 2569 2577 11062277
45. Costs of health care and social services during the first year after ischemic stroke. V Porsdal G Boysen, Int J Technol Assess Health Care 1999 15 573 584 10874383